Slow medication titration: Some dietitians in the study recommended slower dose increases of GLP-1 medications to reduce side effects, helping patients better manage symptoms like nausea while maintaining treatment adherence
Regarding rosiglitazone, RCTs demonstrated a biochemical improvement in liver enzymes and glycemic control both in diabetic and non-diabetic patients with NAFLD, whereas evidence of histological improvement is less clear: results derived from different studies are controversial regarding the effect on steatosis, ballooning, and fibrosis [45, 46, 57, 58]
2 Caldow MK, Ham DJ, Trieu J, Chung JD, Lynch GS, Koopman R
Nooms GLP-1 Companion Receives Major Update to Prepare for New Expected Prescription Drug Use-Related Software (PDURS) Model Noom releases a significant update of its innovative GLP-1 companion to improve medication persistence and adherence while decreasing side effect prevalence and improving lean mass preservation and weight loss outcomes
10.1124/jpet.106.100982 94 ZobelE
You actually pick your provider from a named list